ArticleJournal of computer-aided molecular design2026
PARADOX: pharmacological analysis of relation anomalies and drug contradictions extraction.
Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid expansion of biomedical literature has led to a growing number of contradictory pharmacological reports, where the same drug interactions are described with opposing outcomes across studies. Critically, many such reports are only apparent contradictions arising from mismatched experimental conditions such as dosage, strain, endpoint, or population, rather than logically incompatible claims under comparable settings. These inconsistencies complicate drug safety evaluation and hinder the reliability of automated biomedical knowledge systems. In this paper, we introduce PARADOX, a framework for the detection and analysis of pharmacological contradictions in scientific text. The system integrates BioBERT-based embeddings, a Siamese similarity model, and an iterative refinement using a snowball process to progressively extract and refine conflicting relational statements. Each candidate contradiction is semantically verified using GPT-4o-mini, producing a structured contradiction graph derived from validated outputs. Beyond detection, we introduce a three-stage decision-tree protocol to distinguish real contradictions from apparent ones and outline a conditional biological modulation map that summarizes how identical pharmacological inputs may yield divergent outcomes under different conditions. On more than 18,000 evaluated pairs, the model recovered 39 validated contradiction candidates with only three misses. Qualitative analysis shows both genuine logical conflicts and opposing statements better explained by contextual differences or missing metadata. The results highlight the potential of contradiction-aware mining to strengthen pharmacovigilance, enhance literature consistency checking, and support more robust biomedical reasoning.
Indexed as
Identifiers
42900282What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.